MedPath

Apple

Generic Name
Apple
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
B423VGH5S9
Background

Apple allergenic extract is used in allergenic testing.

Associated Conditions
-
Associated Therapies
-
techcrunch.com
·

Apple AirPods Pro granted FDA approval to serve as hearing aids

Apple’s AirPods Pro 2 to double as hearing aids via software update, pending FDA approval. The FDA has approved the first over-the-counter hearing aid software, enabling accessibility for mild to moderate hearing loss on widely used consumer audio products.
investopedia.com
·

These Stock Analysts Are Bullish on Apple's iPhone 16 Launch—Here's Why

Analysts are bullish on Apple's AI-fueled iPhone 16, but a slow AI feature rollout could delay sales. Health features in new smartwatch and AirPods may drive ecosystem growth. Pre-order data and early sales will gauge consumer interest.
cbc.ca
·

Apple enters new AI era with unveiling of iPhone 16, introduces hearing aid capability for AirPods

Apple's iPhone 16 introduces AI-driven features, including smarter Siri and customizable emojis, marking a significant shift in the smartphone market. The iPhone 16 Pro and Pro Max offer enhanced AI capabilities and faster chips. Apple also unveils new Watches and AirPods, with the latter featuring hearing health advancements.
nbcphiladelphia.com
·

Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs

Over 57 million insured Americans under 65 could be eligible for GLP-1 drugs like Novo Nordisk's Wegovy and Ozempic, according to KFF. These drugs treat Type 2 diabetes or obesity, with Wegovy also reducing heart attack risk. However, employer-sponsored health plans may impose additional eligibility conditions due to high costs. Apple introduces new health features for sleep apnea detection and hearing assistance in its latest products.
investors.com
·

Apple Intelligence Won't Be Available For iPhone 16 Launch

iPhone 16 available Sept. 20, Apple Intelligence in beta next month. AI features initially in U.S. English, expanding to more languages in 2025. Analysts view Apple's AI as not fully ready, similar to competitors. Apple stock dips after EU court upholds tax bill.
kxly.com
·

China's Huawei is set to launch its answer to Apple's iPhone 16

Huawei's latest smartphone, Mate XT, has received over 3 million pre-orders, challenging Apple's iPhone 16. Huawei's comeback includes successful models like Mate 60 Pro and Mate X5, despite US sanctions. The Mate XT, with a rumored double folding structure and large display, aims to compete in the high-end market with Apple, focusing on premium products, software capabilities, and AI deployment.
investors.com
·

Apple Stock Ekes Out Gain On iPhone 16 Rollout (Live Coverage)

Apple's fall product launch unveiled AI-enabled iPhone 16 series, new Apple Watch lineup, and AirPods with over-the-counter hearing aid features. Apple stock dipped 1% post-event, but suppliers like Arm Holdings and Taiwan Semiconductor Manufacturing saw gains.
sharesmagazine.co.uk
·

How Huawei threw a spanner in Apple iPhone 16 launch works

Apple's iPhone 16 launch fails to impress investors, with shares down in pre-market trading. Huawei's successful launch highlights growing competition, especially in China, where Huawei's recovery poses a significant challenge to Apple's market position.
drugs.com
·

Apple Will Sell Air Pods With Hearing Aids Built In

Apple's latest AirPods feature built-in hearing aids for mild to moderate hearing loss, with personalized adjustments via iOS 18 hearing tests. Additionally, new Apple Watch features detect sleep apnea, pending FDA approval.
medwatch.com
·

Apple to launch AirPod hearing aid feature

Apple is launching a feature enabling AirPods to function as OTC hearing aids via a software update, with a hearing test available through the iPhone's health app. The feature aims to help those with hearing loss save money, though it may not match the effectiveness of traditional hearing aids. The update is pending approval by US health authorities and is expected to be available in the US, Germany, and Japan.
© Copyright 2025. All Rights Reserved by MedPath